CLINICAL_TRIALS
trial_result
· 2022-04-20
Clinical Trial Update: Genotype-guided Strategy for Antithrombotic Treatment in Peripheral Arterial Disease. [Phase 4]
Summary
A Phase 4 trial evaluating a genotype-guided strategy for antithrombotic treatment in peripheral arterial disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Radboud University Medical Center | Conditions: Peripheral Arterial Disease | Phase 4 | Status: UNKNOWN